Arizbio
Davis, US · 2 known investors
ARIZ Precision Medicine develops cancer treatments that combine biological and nanotechnology approaches to target the genetic and epigenetic drivers of cancer, aiming to kill cancer cells while leaving healthy cells undamaged. The company designs targeted drug delivery systems intended to concentrate drugs inside cancer cells.
Founders & leadership
BN
Brad NilesChief Executive Officer
GK
Glenn KazoChief Business Officer
Board
LB
Lonnie BookbinderBoard Chairman
Investors · 2
Competitors · 5
by search overlapPrecision Medicine Group, Inc.5 shared keywordsPrecision Medicine Group provides biomarker-driven research and development services and commercialization support for pharmaceutical and life science companies across drug development, manufacturing, and market access.
Clarifiedprecisionmedicine4 shared keywordsClarified Precision Medicine operates a scalable, asynchronous virtual molecular tumor board that combines an expert medical group with an AI-backed platform to interpret genomic tumor profiling tests and recommend guideline-based targeted therapies. It serves oncologists, health systems, payers, and life science partners in the United States, with products for treatment selection (CLARIFIEDSELECT), pharmacogenomics guidance (ONCOGUARDIAN), and clinical data analysis (CLARIFIEDDATA).
Precision For Medicine4 shared keywordsPrecision for Medicine is a contract research organization that provides clinical trial management and regulatory support for drug development programs, including oncology, hematology, cell and gene therapy, CAR-T, and radiopharmaceutical trials. It serves pharmaceutical and biotech sponsors running multinational Phase I–IV studies.
Adelabio3 shared keywordsAdela develops blood-based diagnostic tests that analyze cell-free DNA using whole methylome analysis to detect and monitor cancer. It serves clinicians and biopharma partners with applications including early multi-cancer detection, minimal residual disease detection, and immunotherapy response monitoring.
Ariel Precision Medicine3 shared keywordsAriel Precision Medicine offers an AI-driven platform that integrates genomic and clinical data (including EHR/EMR records, lab results, and scientific literature) to produce peer-reviewed, evidence-based reports. It serves clinicians diagnosing complex diseases and therapeutics developers seeking target discovery and patient stratification.
Companies competing with Arizbio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Arizbio do?
- ARIZ Precision Medicine develops cancer treatments that combine biological and nanotechnology approaches to target the genetic and epigenetic drivers of cancer, aiming to kill cancer cells while leaving healthy cells undamaged. The company designs targeted drug delivery systems intended to concentrate drugs inside cancer cells.
- Who are Arizbio's investors?
- Arizbio's investors include Angel Physicians Fund, Moneta Ventures.
- Where is Arizbio headquartered?
- Arizbio is headquartered in Davis, US.